Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Comparative rates of harms in randomized trials from more developed versus less developed countries may be different — Despina G. Contopoulos‐Ioannidis (2016) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Comparative rates of harms in randomized trials from more developed versus less developed countries may be different
Shared by
John P A Ioannidis
Stanford University
Comparative rates of harms in randomized trials from more developed versus less developed countries may be different
Article
2016
en
Authors
+4 more
DC
Despina G. Contopoulos‐Ioannidis
XT
Xanthippi Tseretopoulou
MA
Megan Ancker
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2017
Comparative evidence on harms in pediatric randomized clinical trials from less developed versus more developed countries is limited
Dario Tedesco
,
Mufiza Farid‐Kapadia
,
Martin Offringa
,
Zulfiqar A Bhutta
,
Yvonne Maldonado
,
John P A Ioannidis
,
Despina G. Contopoulos‐Ioannidis
Article
2013
Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment
Orestis A. Panagiotou
,
Despina G. Contopoulos‐Ioannidis
,
John P A Ioannidis
Article
2018
Extremely large outlier treatment effects may be a footprint of bias in trials from less developed countries: randomized trials of gabapentinoids
Karishma Desai
,
Ian Carroll
,
Steven M. Asch
,
Tina Hernandez‐Boussard
,
John P A Ioannidis
Article
2014
Comparative effect sizes in randomised trials from less developed and more developed countries: a meta-epidemiological assessment
Orestis A. Panagiotou
,
Despina G. Contopoulos‐Ioannidis
,
John P A Ioannidis
Article
2022
Comprehensive Studies of Different Cancer Diseases among Less-Developed Countries
Mohammed M. Rahman
,
F A Dain Md Opo
,
Abdullah Mohamed Asiri
Discussion(0)
No comments yet. Be the first to comment.